Small-Molecule Endoplasmic Reticulum Stress Inducer Triggers Apoptosis in Cancer Cells

Jaypalsing Ingle1, Anjana Tirkey1, Shalini Pandey1

  • 1Department of Chemistry, Indian Institute of Technology Gandhinagar, Palaj, 382355, Gandhinagar, Gujarat, India.

Chemmedchem
|November 15, 2023
PubMed

Insights

Researchers developed a novel small molecule that targets the endoplasmic reticulum (ER), inducing ER stress and apoptosis in cancer cells. This discovery offers a new avenue for developing ER-targeted cancer therapeutics.

Area of Science:

  • Cell Biology
  • Medicinal Chemistry
  • Oncology

Background:

  • The endoplasmic reticulum (ER) is crucial for protein synthesis, modification, and signaling, maintaining cellular homeostasis.
  • ER dysfunction causes ER stress, implicated in various diseases, including cancer.
  • Targeting ER stress is a potential cancer therapeutic strategy, but ER-specific small molecules are lacking.

Purpose of the Study:

  • To synthesize and screen a library of novel small molecules for ER targeting.
  • To identify a small molecule that induces ER stress and apoptosis in cancer cells.
  • To explore the potential of this molecule as an ER-targeted cancer therapeutic.

Main Methods:

  • Synthesis of a 3-methoxy-pyrrole-enamine library.
  • Screening of the library in cervical, colon, breast, and lung cancer cell lines.
  • Confocal microscopy for ER localization, Western blotting for ER stress markers, and apoptosis assays.

Main Results:

  • A novel small molecule was identified that localizes to the ER in HeLa cervical cancer cells within 3 hours.
  • This molecule significantly increased ER stress markers (CHOP, IRE1α, PERK, BiP, Cas-12).
  • The molecule triggered apoptosis and led to substantial HeLa cell death.

Conclusions:

  • A novel ER-targeting small molecule was successfully synthesized and validated.
  • This molecule effectively induces ER stress and apoptosis in cancer cells.
  • The findings support further investigation of this molecule for developing novel ER-targeted cancer therapeutics.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.4K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.5K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K